Arnaud Fontanet

Prof. Dr. Arnaud Fontanet


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in The Lancet
Verified
Journal Article
Closed access
VCVan-Mai Cao-Lormeau
Van-Mai Cao-Lormeau
ABAlexandre Blake
Alexandre Blake
SMSandrine Mons
Sandrine Mons
SLStéphane Lastère
Stéphane Lastère
CRClaudine Roche
Claudine Roche
FGFrédéric Ghawché
Frédéric Ghawché

1 March 2021 in The Lancet
Verified
Journal Article
Closed access
AFArnaud Fontanet
Arnaud Fontanet
BABrigitte Autran
Brigitte Autran
BLBruno Lina
Bruno Lina
MKMarie Paule Kieny
Marie Paule Kieny
SKSalim S Abdool Karim
Salim S Abdool Karim
DSDevi Sridhar
Devi Sridhar

9 September 2020 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
AFArnaud Fontanet
Arnaud Fontanet
SCSimon Cauchemez
Simon Cauchemez

1 August 2013 in The Lancet
Verified
Journal Article
Closed access
RBRomulus Breban
Romulus Breban
JRJulien Riou
Julien Riou
AFArnaud Fontanet
Arnaud Fontanet

6 February 2012 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
JGJ. Guerra
J. Guerra
MGM. Garenne
M. Garenne
MMM. K. Mohamed
M. K. Mohamed
AFArnaud Fontanet
Arnaud Fontanet

26 November 2021 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
RGRebecca Grant
Rebecca Grant
TCTiffany Charmet
Tiffany Charmet
LSLaura Schaeffer
Laura Schaeffer
SGSimon Galmiche
Simon Galmiche
YMYoann Madec
Yoann Madec
AFArnaud Fontanet
Arnaud Fontanet
We aimed to assess the settings and activities associated with SARS-CoV-2 infection in the context of B.1.617.2 (Delta) variant circulation in France, as well as the protection against symptomatic Delta infection. In this nationwide case-control study, cases were SARS-CoV-2 infected adults recruited between 23 May and 13 August 2021. Controls were non-infected adults from a national representative panel matched to cases by age, sex, region, population density and calendar week. Participants completed an online questionnaire and multivariable logistic regression analysis was used to determine the association between acute SARS-CoV-2 infection and recent activity-related exposures, past history of SARS-CoV-2 infection, and COVID-19 vaccination. We did not find any differences in the settings and activities associated with Delta versus non-Delta infections and grouped them for subsequent analyses. In multivariable analysis involving 12634 cases (8644 Delta and 3990 non-Delta) and 5560 controls, we found individuals under 40 years and attending bars (aOR:1.9; 95%CI:1.6-2.2) or parties (aOR:3.4; 95%CI:2.8-4.2) to be at increased risk of infection. In those aged 40 years and older, having children attend daycare (aOR:1.9; 95%CI:1.1-3.3), kindergarten (aOR:1.6; 95%CI:1.2-2.1), primary school (aOR:1.4; 95%CI:1.2-1.6) or middle school (aOR:1.3; 95%CI:1.2-1.6) were associated with increased risk of infection. We found strong protection against symptomatic Delta infection for those with prior infection whether it was recent (2-6 months) (95%; 95%CI:90-97) or associated with one dose (85%; 95%CI:78-90) or two doses of mRNA vaccine (96%; 95%CI:87-99). For those without past infection, protection was lower with two doses of mRNA vaccine (67%; 95%CI:63-71). In line with other observational studies, we find reduced vaccine effectiveness against symptomatic Delta infections. The settings and activities at increased risk of infection indicate where efforts to reinforce individual and public health measures need to be concentrated.